Literature DB >> 26307010

Conformational change results in loss of enzymatic activity of jack bean urease on its interaction with silver nanoparticle.

Shobana Ponnuvel1, Balakumar Subramanian2, Karthe Ponnuraj3.   

Abstract

Urease is an enzyme produced by microbes such as bacteria, yeast and fungi. Plants also produce this enzyme. Urease action splits urea into ammonia and carbamate. This action is having important implications in agro-chemical, medicinal and environment. Therefore there is always a constant search for new and novel compounds which could inhibit this enzyme. Here we have studied the interaction of jack bean urease (JBU) with silver nanoparticle to analyze the influence of the resultant protein corona formation on the catalytic property of JBU. Several techniques like UV-Vis, gel shift assay and CD spectroscopy have been used to characterize this interaction. Urease activity assay suggests that the protein corona formation inhibits the enzymatic action of JBU. The loss of enzymatic action could be either due to the nanoparticle blocking the active site of JBU or a conformational change in the protein. The CD spectra of JBU-AgNP complexes clearly revealed significant changes in the secondary structural composition of the JBU and this could be the reason for the loss of enzymatic activity of JBU. This study revealed an interesting observation, where the interaction of AgNP with JBU resulted destabilization of hexameric nature of JBU which is otherwise highly stable. The results of the present study could be useful in the development of nanoparticle based material for inhibiting the ureolytic activity of ureases in different fields.

Entities:  

Keywords:  Circular dichroism (CD); Conformational change; Enzyme-nanoparticle corona; Jack bean urease (JBU); Silver nanoparticle (AgNP)

Mesh:

Substances:

Year:  2015        PMID: 26307010     DOI: 10.1007/s10930-015-9627-9

Source DB:  PubMed          Journal:  Protein J        ISSN: 1572-3887            Impact factor:   2.371


  19 in total

1.  Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology.

Authors:  Stefan Tenzer; Dominic Docter; Jörg Kuharev; Anna Musyanovych; Verena Fetz; Rouven Hecht; Florian Schlenk; Dagmar Fischer; Klytaimnistra Kiouptsi; Christoph Reinhardt; Katharina Landfester; Hansjörg Schild; Michael Maskos; Shirley K Knauer; Roland H Stauber
Journal:  Nat Nanotechnol       Date:  2013-09-22       Impact factor: 39.213

Review 2.  Urease inhibitors as potential drugs for gastric and urinary tract infections: a patent review.

Authors:  Paulina Kosikowska; Łukasz Berlicki
Journal:  Expert Opin Ther Pat       Date:  2011-04-04       Impact factor: 6.674

3.  Inhibition of urease activity by hydroxamic acid derivatives of amino acids.

Authors:  K Kobashi; S Takebe; N Terashima; J Hase
Journal:  J Biochem       Date:  1975-04       Impact factor: 3.387

Review 4.  Helicobacter pylori virulence and genetic geography.

Authors:  A Covacci; J L Telford; G Del Giudice; J Parsonnet; R Rappuoli
Journal:  Science       Date:  1999-05-21       Impact factor: 47.728

5.  Toxicity and cellular uptake of gold nanoparticles: what we have learned so far?

Authors:  Alaaldin M Alkilany; Catherine J Murphy
Journal:  J Nanopart Res       Date:  2010-04-06       Impact factor: 2.253

6.  Mono- (Ag, Hg) and di- (Cu, Hg) valent metal ions effects on the activity of jack bean urease. Probing the modes of metal binding to the enzyme.

Authors:  Barbara Krajewska
Journal:  J Enzyme Inhib Med Chem       Date:  2008-08       Impact factor: 5.051

7.  Synthesis of silver and silver/gold anisotropic nanostructures for surface enhanced Raman spectroscopy applications.

Authors:  M Sakar; P Parthiban; S Balakumar
Journal:  J Nanosci Nanotechnol       Date:  2013-12

8.  Jack bean urease (EC 3.5.1.5). V. On the mechanism of action of urease on urea, formamide, acetamide, N-methylurea, and related compounds.

Authors:  N E Dixon; P W Riddles; C Gazzola; R L Blakeley; B Zerner
Journal:  Can J Biochem       Date:  1980-12

Review 9.  Interaction of nanoparticles with proteins: relation to bio-reactivity of the nanoparticle.

Authors:  Shruti R Saptarshi; Albert Duschl; Andreas L Lopata
Journal:  J Nanobiotechnology       Date:  2013-07-19       Impact factor: 10.435

Review 10.  Immunomodulation of nanoparticles in nanomedicine applications.

Authors:  Qing Jiao; Liwen Li; Qingxin Mu; Qiu Zhang
Journal:  Biomed Res Int       Date:  2014-05-20       Impact factor: 3.411

View more
  5 in total

1.  Investigating the Interaction of Fe Nanoparticles with Lysozyme by Biophysical and Molecular Docking Studies.

Authors:  Zahra Aghili; Saba Taheri; Hojjat Alizadeh Zeinabad; Leila Pishkar; Ali Akbar Saboury; Arash Rahimi; Mojtaba Falahati
Journal:  PLoS One       Date:  2016-10-24       Impact factor: 3.240

Review 2.  Nanosilver: new ageless and versatile biomedical therapeutic scaffold.

Authors:  Shahid Ullah Khan; Tawfik A Saleh; Abdul Wahab; Muhammad Hafeez Ullah Khan; Dilfaraz Khan; Wasim Ullah Khan; Abdur Rahim; Sajid Kamal; Farman Ullah Khan; Shah Fahad
Journal:  Int J Nanomedicine       Date:  2018-02-02

3.  Gold nanoparticles partition to and increase the activity of glucose-6-phosphatase in a synthetic phospholipid membrane system.

Authors:  Tyson J MacCormack; Amanda M Rundle; Michael Malek; Abhilash Raveendran; Maria-Victoria Meli
Journal:  PLoS One       Date:  2017-08-17       Impact factor: 3.240

Review 4.  A minireview on what we have learned about urease inhibitors of agricultural interest since mid-2000s.

Authors:  Luzia V Modolo; Cristiane J da-Silva; Débora S Brandão; Izabel S Chaves
Journal:  J Adv Res       Date:  2018-04-17       Impact factor: 10.479

5.  Surface functionalization-specific binding of coagulation factors by zinc oxide nanoparticles delays coagulation time and reduces thrombin generation potential in vitro.

Authors:  Jun-Young Yang; Jiyeong Bae; Ayoung Jung; Seonyeong Park; Seungtae Chung; Jihyun Seok; Hangsik Roh; Youngju Han; Jae-Min Oh; Soojung Sohn; Jayoung Jeong; Wan-Seob Cho
Journal:  PLoS One       Date:  2017-07-19       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.